Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$37.54
▼ $0.65 (-1.7%)
Market data updated: 09/20 08:08 AM
Fundamentals updated: 09/19/2026
News analyzed: 09/20/2026
Market Cap
$20.53B
Day Range
$37.38 - $37.92
52-Week Range
$37.38 - $65.94
Beta
—
Next Earnings
29.10.2026
Support
$37.38
Resistance
$53.01
AMRZ is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
-28.1% (1Y)
Strengths: 3/29 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Liquidity risk
Current ratio: 1.64
Risk
Biggest negative driver
Operating margin stability
Operating margin is eroding over time
Quality
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
36
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
34
Quality
42
Value
50
Momentum
6
Risk
48
Sentiment
38
Fundamental
59
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Amrize Ltd has centered on analyst downgrades and reduced price targets. Bank of America and JP Morgan downgraded the company to Underperform and Neutral, respectively, citing slower earnings growth and market risks, while lowering their price targets from $50 to $40 and $57 to $52. Additionally, an insider purchased shares worth $1.27 million, as reported by SEC filings.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Amrize Ltd. News trend score: 38. Reason: 8 of the last 20 articles are negative, versus 6 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
34
🎯 Conviction (vs. Emotion)
35
Psychology
91
Fundamentals
59
Technical
6
Valuation
50
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-32%
Market Narrative
22
Fundamental Reality
35
Narrative Gap
-13
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The dominant anchoring behavior (73) reflects traders’ fixation on a near-term support level (1.4% away), despite broader market weakness and negative momentum. Loss aversion (22) and herding (19) are secondary, suggesting hesitation to exit positions amid downtrends. The narrative gap (2) is minimal, implying no severe disconnect between market sentiment and fundamentals. The key question is whether traders will defend support or capitulate if momentum worsens, given the lack of euphoria or panic extremes.
Updated: 09/09/2026, 03:10 AM
What could change this?
👥 What the crowd believes
"JP Morgan Downgrades Amrize (AMRZ) from Overweight to Neutral and lowers the price target from $57 to $52"
"Bank of America downgraded Amrize to Underperform from Neutral... cuts its price target to $40 from $50"
"Bank of America downgraded Amrize... citing slower earnings growth"
📈 17D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Charles Mackay — 100/100
🔴 Weakest match
Peter Lynch — 9/100
🗣️ Why do they disagree?
This stock’s starkly divided verdicts reflect a clash between cyclical, trend-following, and fundamentalist perspectives. The highest-scoring methodologies—Charles Mackay, Howard Marks (Market Cycle), and Jack Schwager—see it as a disciplined, early-to-mid-cycle opportunity with favorable risk/reward, avoiding mania or overvaluation. Meanwhile, the lowest-ranked investors—Peter Lynch, Philip Fisher, and Morgan Housel—reject it outright, dismissing it as lacking growth, quality, or patient-holder endurance. Benjamin Graham’s strict defensive criteria and the efficient-market camp further undermine confidence, while moderate-risk frameworks (Loeb, Bagehot) and cyclical analysts (Nelson, Marks) sit in the middle, acknowledging some merit but not enough to justify aggressive bets. The debate hinges on whether the stock’s volatility and lack of defensive traits are temporary cyclical dips or fundamental flaws.
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 100
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 100
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 99
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 80
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 79
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 49
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 46
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 46
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 42
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🔴 32
Doesn't show the stability Smith's long-term case requires
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🔴 30
Weak case — Malkiel/Bogle would say a low-cost index is the simpler bet
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 28
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 16
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 13
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 9
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 11 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
25.7%
Operating Margin
16.1%
Net Margin
10.0%
EBITDA Margin
22.5%
ROE
8.9%
ROA
4.9%
ROIC
—
EPS
$2.14
Cash
$1.92B
Total Debt
—
Current Ratio
1.64
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 18.8.2026 | $0.110 |
| 12.5.2026 | $0.110 |
| 11.5.2026 | $0.110 |
| 24.4.2026 | $0.440 |
| 23.4.2026 | $0.440 |
How is Fair Value calculated? →
Current Price
$37.54
Estimated Fair Value (DCF)
$38.70
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+3.1%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
0.6%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 0.6% | $1.43B | $1.31B |
| 2 | 1.1% | $1.44B | $1.22B |
| 3 | 1.5% | $1.47B | $1.13B |
| 4 | 2.0% | $1.50B | $1.06B |
| 5 | 2.5% | $1.53B | $996.32M |
Base FCF (last actual year)
$1.42B
Terminal Value
$24.17B
Present Value of Terminal Value
$15.71B
Enterprise Value
$21.42B
Net Debt
$0
Equity Value
$21.42B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$23.95
Tangible Book Value per Share (Tangible NAV)
$4.53
Sentiment based on basic keywords (not AI) — 6 positive, 6 neutral, 8 negative out of the last 20 articles.
Benzinga · 18.9.2026
Yahoo · 18.9.2026
Yahoo · 17.9.2026
Yahoo · 16.9.2026
Yahoo · 15.9.2026
Yahoo · 11.9.2026
Business Wire · 11.9.2026
Benzinga · 10.9.2026
Yahoo · 9.9.2026
The Fly · 9.9.2026
The Fly · 9.9.2026
Benzinga · 9.9.2026
Benzinga · 9.9.2026
Fintel · 3.9.2026
Fintel · 3.9.2026
MT Newswires · 3.9.2026
Benzinga · 2.9.2026
Yahoo · 2.9.2026
The Fly · 2.9.2026
Yahoo · 2.9.2026
Amrize Ltd (AMRZ) currently has a StockIQ AI score of 36/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AMRZ currently scores 36/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, AMRZ's estimated fair value is $38.70, which is 3.1% above the current price of $37.54. This is one valuation model among several signals in the fair-value category, not a price target.
AMRZ's technical score is 6/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Current ratio: 1.64; Current ratio: 1.64; Interest coverage: 8.8x.
Based on the real signals StockIQ computed: Operating margin is eroding over time; Calmar: -0.54 (3y annualized return -23.1% / max drawdown 43.0%); Earnings per share (EPS) growth: -7.0%.
Yes — AMRZ has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 25 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Jenisch Jan Philipp | Open Market Purchase | 2.9.2026 | 15,000 | +15,000 | $42.53 |
| Jenisch Jan Philipp | Open Market Purchase | 2.9.2026 | 1,000 | +1,000 | $42.44 |
| Jenisch Jan Philipp | Open Market Purchase | 2.9.2026 | 2,000 | +2,000 | $42.47 |
| Jenisch Jan Philipp | Open Market Purchase | 2.9.2026 | 2,000 | +2,000 | $42.53 |
| Jenisch Jan Philipp | Open Market Purchase | 2.9.2026 | 10,000 | +10,000 | $42.37 |
| Gibson Dwight Audley Konrad | Open Market Purchase | 27.8.2026 | 5,199 | +5 | $44.58 |
| Gibson Dwight Audley Konrad | Open Market Purchase | 27.8.2026 | 5.47 | +5.47 | $44.58 |
| Sanche Jacques Wolf | Open Market Purchase | 26.8.2026 | 9,766 | +4,150 | $45.02 |
| Sanche Jacques Wolf | Open Market Purchase | 26.8.2026 | 4,150 | +4,150 | $45.02 |
| Singleton Denise R | Open Market Purchase | 25.8.2026 | 7,500 | +3,500 | $44.12 |
| Forrest Nollaig | Open Market Purchase | 25.8.2026 | 21,639 | +1,500 | $44.15 |
| Singleton Denise R | Open Market Purchase | 25.8.2026 | 3,500 | +3,500 | $44.12 |
| Forrest Nollaig | Open Market Purchase | 25.8.2026 | 1,500 | +1,500 | $44.15 |
| Poletti Samuel Jonas | Open Market Purchase | 17.8.2026 | 2,510 | +2,510 | $46.92 |
| Oran Baris | Open Market Purchase | 12.8.2026 | 3,000 | +3,000 | $47.13 |
| Oran Baris | Open Market Purchase | 12.8.2026 | 6,000 | +3,000 | $47.13 |
| Brouwer Roald | Open Market Purchase | 11.8.2026 | 1,500 | +1,500 | $46.36 |
| Gross Mario | Open Market Purchase | 11.8.2026 | 3,200 | +3,200 | $46.62 |
| Gross Mario | Open Market Purchase | 11.8.2026 | 368 | +368 | $46.38 |
| Hill Jaime | Open Market Purchase | 11.8.2026 | 1,500 | +1,500 | $47.12 |
| Clark Stephen S | Open Market Purchase | 11.8.2026 | 5,260 | +5,260 | $47.31 |
| Oran Baris | Open Market Purchase | 11.8.2026 | 3,000 | +3,000 | $47.38 |
| Clark Stephen S | Open Market Purchase | 11.8.2026 | 10,637 | +5,260 | $47.31 |
| Oran Baris | Open Market Purchase | 11.8.2026 | 3,000 | +3,000 | $47.38 |
| Brouwer Roald | Open Market Purchase | 11.8.2026 | 21,490 | +1,500 | $46.36 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
9,188,967 shares short as of 2026-08-31 · vs. 8,016,985 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
49.3% of trading volume this week was short selling, vs. 45.7% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology